A narrative review of advances in treatment and survival prognosis of HER2-positive malignant lung cancers

Human epidermal growth factor receptor 2 (HER2), as a receptor tyrosine kinase of EGF receptor family, whose mutation is often associated with even if less frequency but poor prognosis and shorter survival in pulmonary malignant tumor. HER2 status include mutation, overexpression, amplification and...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Ranpu, Yuan, Bingxiao, Li, Chuling, Wang, Zimu, Song, Yong, Liu, Hongbing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8264687/
https://www.ncbi.nlm.nih.gov/pubmed/34277062
http://dx.doi.org/10.21037/jtd-20-3265

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8264687/
https://www.ncbi.nlm.nih.gov/pubmed/34277062
http://dx.doi.org/10.21037/jtd-20-3265

Ejemplares similares